Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD: A Pilot Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04889664

Organisation Name: Icahn School of Medicine at Mount Sinai

Overal Status: Recruiting

Start Date: June 4, 2021

Last Update: June 11, 2021

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Brief Summary: The current project will evaluate the efficacy of adding Written Exposure Therapy (WET) to a course of repeated IV ketamine infusions in prolonging PTSD symptom improvement/time to loss of response in patients with chronic PTSD who show an initial response to ketamine (to the first four infusions). WET is a brief, 5-session evidence-based written trauma-focused therapy without in between-session assignments, with demonstrated efficacy and low dropout rates in patients with PTSD. WET will be administered to participants who respond to four initial ketamine infusions; the first WET sessions will be interleaved with two additional ketamine infusions to take advantage of a window of increased neuroplasticity potentially induced by repeated ketamine infusions. WET will be administered on different days as the ketamine infusions.

Conditions:
  • PTSD


Total execution time in seconds: 0.27077603340149